(2S,4R)-4-(2-Cyanobenzyl)pyrrolidine-2-carboxylic acid
≥95%
- Product Code: 36557
CAS:
1049981-76-1
Molecular Weight: | 230.26 g./mol | Molecular Formula: | C₁₃H₁₄N₂O₂ |
---|---|---|---|
EC Number: | MDL Number: | MFCD28968084 | |
Melting Point: | Boiling Point: | 438.3±40.0°C at 760 mmHg | |
Density: | Storage Condition: | Room temperature, away from light, stored in an inert gas |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of pharmaceutical agents. Its structural features, including the pyrrolidine ring and the cyanobenzyl group, make it a valuable building block for developing molecules with potential therapeutic effects. It is often employed in the design of enzyme inhibitors, particularly those targeting proteases or other biologically relevant enzymes. Additionally, its chiral centers allow for the creation of stereospecific drugs, enhancing their efficacy and reducing side effects. Researchers also explore its use in the development of ligands for receptor binding studies, aiding in the discovery of new drugs for neurological and metabolic disorders.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.100 | 10-20 days | $391.91 |
+
-
|
0.250 | 10-20 days | $784.28 |
+
-
|
(2S,4R)-4-(2-Cyanobenzyl)pyrrolidine-2-carboxylic acid
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of pharmaceutical agents. Its structural features, including the pyrrolidine ring and the cyanobenzyl group, make it a valuable building block for developing molecules with potential therapeutic effects. It is often employed in the design of enzyme inhibitors, particularly those targeting proteases or other biologically relevant enzymes. Additionally, its chiral centers allow for the creation of stereospecific drugs, enhancing their efficacy and reducing side effects. Researchers also explore its use in the development of ligands for receptor binding studies, aiding in the discovery of new drugs for neurological and metabolic disorders.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :